| Active Ingredient | Mycophenolate Sodium |
| Brand | Mycofoli |
| Country of origin | India |
| Form | Oral tablets |
Mycofoli contains Mycophenolate Sodium which is an immunosuppressive agent. This medicine belongs to the antimetabolite class of medicines. Mycofoli tablet is used to prevent organ rejection in patients after a transplantation.
Clinical Uses
Mycofoli tablet is used to prevent organ rejection in patients with kidney transplantation. It works with other immunosuppressive medicines to help the body accept the transplanted organ.
Dosage Strengths
Mycofoli Mycophenolate Sodium tablets are available in the following dosage strengths-
- 180mg
- 360mg
- 720mg
The right dosage option will be determined by your doctor depending on your health condition.
How It Works
Mycofoli Mycophenolate Sodium tablets works by suppressing the activity of the immune system. It inhibits an enzyme called inosine monophosphate dehydrogenase (IMPDH) which is important for the growth and multiplication of T and B lymphocytes. This reduces the immune response against the transplanted organ and helps prevent rejection.
Side Effects
Common side effects include-
- Nausea
- Abdominal discomfort
- Headache
- Anaemia
- Urinary tract infections
- Increased susceptibility to infections
Serious side effects may include severe infections, gastrointestinal bleeding, and blood-related disorders.
Precautions & Warnings
- The use of this medicine can increase the risk of serious infections because it suppresses the immune system.
- Avoid excessive sunlight and UV exposure and use adequate sun protection.
- Mycofoli should not be used during pregnancy unless specifically directed by a specialist.
- Women should use effective contraception during treatment and for 6 weeks after stopping the medicine.
- Breastfeeding is not recommended during treatment as recommended by a doctor.
- This medicine may cause low white blood cell counts, anaemia, and low platelet counts, increasing the risk of infections and bleeding.
- Avoid taking any vaccines during the treatment. Consult your doctor before receiving any vaccine.
- Do not take this tablet if you have a known allergy to mycophenolate sodium or related medicines.
Drug Interactions
A few medicines that doctors do not recommend taking with Mycofoli Mycophenolate Sodium tablets include-
- Antacids
- Acyclovir
- Azathioprine
- Cholestyramine
- Rifampicin
- Cyclosporine
- Oral contraceptives
- Other immunosuppressants
- Sevelamer
- Proton pump inhibitors (PPIs) such as omeprazole and pantoprazole.
This is not a complete list of all the possible drug interactions of Mycofoli tablets. Consult a doctor before taking any medicine and supplement with Mycofoli.
Disclaimer
At 5M Biotech India we provide accurate, reliable and expert reviewed information. However, all our content on this platform is intended for informational purposes only and is not professional medical advice, diagnosis or treatment. While we make efforts to maintain accuracy, the information may contain mistakes, omissions or may not reflect the latest developments. Always consult your doctor regarding any medical concerns.
All medicine names, trademarks, and registered trademarks displayed on 5M Biotech India are property of their respective owners. 5M Biotech India and its operator are not affiliated with, endorsed by or authorized by any such trademark owners unless stated expressly. Any reference to trademarks or product names is made for informational purposes. No sponsorship, commercial relationship, approval or association with any trademark owner should be inferred. Information provided herein does not constitute advertising, promotion or an offer for sale of any medicinal goods and is intended solely for general informational purposes.
All trademarks, trade names, and brand names displayed on this website are used strictly in accordance with the applicable provisions of the Trade Marks Act, 1999, including Sections 30 and 30(1) relating to permitted and fair use. The respective trademark ownership has been duly and accurately identified under the “Manufacturer/TM Owner” section in compliance with applicable statutory requirements.
